AstraZeneca & Pangaea Partner to Advance AI-Powered Precision Healthcare

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

Pangaea Data enters AI collaboration with Alexion to help improve detection of HPP in adults

Pangaea Data Secures Strategic Investment from Topcon Healthcare to Close Care Gaps in Eye Care

GO BACK

Pangaea Data is Attending HLTH Europe 2026

June 15th - 18th, 2026, Amsterdam, Netherlands

Meet us to learn how Pangaea’s AI platform closes care gaps across hard-to-diagnose conditions based on clinical guidelines. Seamlessly integrated into existing EHR systems and workflows, the platform flags patients who would otherwise be untreated or under-treated despite information in their records. This is helping to improve patient outcomes through multiple clinical purposes at the point of care and for population health, optimizing MDTs (tumor boards) and matching patients for clinical trials, while reducing costs (through early diagnosis and improved triaging) and increasing revenues (through improved prior authorizations and treatments) in a sustainable and compliant manner. The platform is now scaling across 14 countries. 

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Attendees

Vibhor Gupta, PhD
Founder & CEO,
Pangaea Data
Emily Comins
Biomedical Analyst
Pangaea Data